Global Anti-Obesity Drugs (Anti-obesity Medication) Market Report 2021
Global Anti-Obesity Drugs (Anti-obesity Medication) Market Report 2021
Anti Obesity Drugs (Anti obesity Medication) Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
At the beginning of 2020, COVID-19 disease began to spread around the world, millions of people worldwide were infected with COVID-19 disease, and major countries around the world have implemented foot prohibitions and work stoppage orders. Except for the medical supplies and life support products industries, most industries have been greatly impacted, and Anti-Obesity Drugs (Anti-obesity Medication) industries have also been greatly affected.
In the past few years, the Anti-Obesity Drugs (Anti-obesity Medication) market experienced a growth of xx, the global market size of Anti-Obesity Drugs (Anti-obesity Medication) reached xx million $ in 2020, of what is about xx million $ in 2015.
From 2015 to 2019, the growth rate of global Anti-Obesity Drugs (Anti-obesity Medication) market size was in the range of xxx%. At the end of 2019, COVID-19 began to erupt in China, Due to the huge decrease of global economy; we forecast the growth rate of global economy will show a decrease of about 4%, due to this reason, Anti-Obesity Drugs (Anti-obesity Medication) market size in 2020 will be xx with a growth rate of xxx%. This is xxx percentage points lower than in previous years.
As of the date of the report, there have been more than 20 million confirmed cases of CVOID-19 worldwide, and the epidemic has not been effectively controlled. Therefore, we predict that the global epidemic will be basically controlled by the end of 2020 and the global Anti-Obesity Drugs (Anti-obesity Medication) market size will reach xx million $ in 2025, with a CAGR of xxx% between 2020-2025.
This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.
Section 1: Free——Definition
Section (2 3): 1200 USD——Manufacturer Detail
Zafgan
Vivus
Shionogi
Sanofi
Rhythm Pharmaceuticals
Pfizer
Orexigen Therapeutics
Novo Nordisk
Norgine
Nalpropion Pharmaceuticals Inc.
Merck
GlaxoSmithKline
F.Hoffmann-La Roche
Eisai
Boehringer Ingelheim
Bayer AG
AstraZeneca
Arena Pharmaceuticals
Amylin
Alizyme
Section 4: 900 USD——Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7): 500 USD——
Product Type Segmentation
by Drug Varieties
Prescription Drugs
OTC Drugs
by Acting
Peripherally Acting Anti-obesity Drugs/Centrally Acting Anti-obesity Drugs
Industry Segmentation
Childhood (0-6)
Juvenile (7-17)
Youth (18-40)
Middle Aged (41-60)
Elderly (Above 60)
Channel (Direct Sales, Distributor) Segmentation
Section 8: 400 USD——Trend (2020-2025)
Section 9: 300 USD——Product Type Detail
Section 10: 700 USD——Downstream Consumer
Section 11: 200 USD——Cost Structure
Section 12: 500 USD——Conclusion
Section 1 Anti-Obesity Drugs (Anti-obesity Medication) Product Definition
Section 2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Anti-Obesity Drugs (Anti-obesity Medication) Shipments
2.2 Global Manufacturer Anti-Obesity Drugs (Anti-obesity Medication) Business Revenue
2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Overview
2.4 COVID-19 Impact on Anti-Obesity Drugs (Anti-obesity Medication) Industry
Section 3 Manufacturer Anti-Obesity Drugs (Anti-obesity Medication) Business Introduction
3.1 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Business Introduction
3.1.1 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Shipments, Price, Revenue and Gross profit 2015-2020
3.1.2 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Business Distribution by Region
3.1.3 Zafgan Interview Record
3.1.4 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Business Profile
3.1.5 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Specification
3.2 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Business Introduction
3.2.1 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Shipments, Price, Revenue and Gross profit 2015-2020
3.2.2 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Business Distribution by Region
3.2.3 Interview Record
3.2.4 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Business Overview
3.2.5 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Specification
3.3 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Business Introduction
3.3.1 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Shipments, Price, Revenue and Gross profit 2015-2020
3.3.2 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Business Distribution by Region
3.3.3 Interview Record
3.3.4 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Business Overview
3.3.5 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Specification
3.4 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Business Introduction
3.5 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Business Introduction
3.6 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Business Introduction
…
Section 4 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Price Analysis 2015-2020
4.1.2 Canada Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Price Analysis 2015-2020
4.2 South America Country
4.2.1 South America Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Price Analysis 2015-2020
4.3 Asia Country
4.3.1 China Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Price Analysis 2015-2020
4.3.2 Japan Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Price Analysis 2015-2020
4.3.3 India Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Price Analysis 2015-2020
4.3.4 Korea Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Price Analysis 2015-2020
4.4 Europe Country
4.4.1 Germany Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Price Analysis 2015-2020
4.4.2 UK Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Price Analysis 2015-2020
4.4.3 France Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Price Analysis 2015-2020
4.4.4 Italy Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Price Analysis 2015-2020
4.4.5 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Price Analysis 2015-2020
4.5 Other Country and Region
4.5.1 Middle East Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Price Analysis 2015-2020
4.5.2 Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Price Analysis 2015-2020
4.5.3 GCC Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Price Analysis 2015-2020
4.6 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Segmentation (Region Level) Analysis 2015-2020
4.7 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Segmentation (Region Level) Analysis
Section 5 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Segmentation (Product Type Level)
5.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Segmentation (Product Type Level) Market Size 2015-2020
5.2 Different Anti-Obesity Drugs (Anti-obesity Medication) Product Type Price 2015-2020
5.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Segmentation (Product Type Level) Analysis
Section 6 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Segmentation (Industry Level)
6.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Segmentation (Industry Level) Market Size 2015-2020
6.2 Different Industry Price 2015-2020
6.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Segmentation (Industry Level) Analysis
Section 7 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Segmentation (Channel Level)
7.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Segmentation (Channel Level) Sales Volume and Share 2015-2020
7.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Segmentation (Channel Level) Analysis
Section 8 Anti-Obesity Drugs (Anti-obesity Medication) Market Forecast 2020-2025
8.1 Anti-Obesity Drugs (Anti-obesity Medication) Segmentation Market Forecast (Region Level)
8.2 Anti-Obesity Drugs (Anti-obesity Medication) Segmentation Market Forecast (Product Type Level)
8.3 Anti-Obesity Drugs (Anti-obesity Medication) Segmentation Market Forecast (Industry Level)
8.4 Anti-Obesity Drugs (Anti-obesity Medication) Segmentation Market Forecast (Channel Level)
Section 9 Anti-Obesity Drugs (Anti-obesity Medication) Segmentation Product Type
9.1 by Drug Varieties Product Introduction
9.2 Prescription Drugs Product Introduction
9.3 OTC Drugs Product Introduction
9.4 by Acting Product Introduction
9.5 Peripherally Acting Anti-obesity Drugs/Centrally Acting Anti-obesity Drugs Product Introduction
Section 10 Anti-Obesity Drugs (Anti-obesity Medication) Segmentation Industry
10.1 Childhood (0-6) Clients
10.2 Juvenile (7-17) Clients
10.3 Youth (18-40) Clients
10.4 Middle Aged (41-60) Clients
10.5 Elderly (Above 60) Clients
Section 11 Anti-Obesity Drugs (Anti-obesity Medication) Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview
Section 12 Conclusion
Chart and Figure
Figure Anti-Obesity Drugs (Anti-obesity Medication) Product Picture from Zafgan
Chart 2015-2020 Global Manufacturer Anti-Obesity Drugs (Anti-obesity Medication) Shipments (Units)
Chart 2015-2020 Global Manufacturer Anti-Obesity Drugs (Anti-obesity Medication) Shipments Share
Chart 2015-2020 Global Manufacturer Anti-Obesity Drugs (Anti-obesity Medication) Business Revenue (Million USD)
Chart 2015-2020 Global Manufacturer Anti-Obesity Drugs (Anti-obesity Medication) Business Revenue Share
Chart Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Shipments, Price, Revenue and Gross profit 2015-2020
Chart Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Business Distribution
Chart Zafgan Interview Record (Partly)
Figure Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Picture
Chart Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Business Profile
Table Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Specification
Chart Vivus Anti-Obesity Drugs (Anti-obesity Medication) Shipments, Price, Revenue and Gross profit 2015-2020
Chart Vivus Anti-Obesity Drugs (Anti-obesity Medication) Business Distribution
Chart Vivus Interview Record (Partly)
Figure Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Picture
Chart Vivus Anti-Obesity Drugs (Anti-obesity Medication) Business Overview
Table Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Specification
Chart Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Shipments, Price, Revenue and Gross profit 2015-2020
Chart Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Business Distribution
Chart Shionogi Interview Record (Partly)
Figure Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Picture
Chart Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Business Overview
Table Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Specification
3.4 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Business Introduction
…
Chart United States Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart United States Anti-Obesity Drugs (Anti-obesity Medication) Sales Price ($/Unit) 2015-2020
Chart Canada Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Canada Anti-Obesity Drugs (Anti-obesity Medication) Sales Price ($/Unit) 2015-2020
Chart South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Price ($/Unit) 2015-2020
Chart China Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart China Anti-Obesity Drugs (Anti-obesity Medication) Sales Price ($/Unit) 2015-2020
Chart Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales Price ($/Unit) 2015-2020
Chart India Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart India Anti-Obesity Drugs (Anti-obesity Medication) Sales Price ($/Unit) 2015-2020
Chart Korea Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Korea Anti-Obesity Drugs (Anti-obesity Medication) Sales Price ($/Unit) 2015-2020
Chart Germany Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Germany Anti-Obesity Drugs (Anti-obesity Medication) Sales Price ($/Unit) 2015-2020
Chart UK Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart UK Anti-Obesity Drugs (Anti-obesity Medication) Sales Price ($/Unit) 2015-2020
Chart France Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart France Anti-Obesity Drugs (Anti-obesity Medication) Sales Price ($/Unit) 2015-2020
Chart Italy Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Italy Anti-Obesity Drugs (Anti-obesity Medication) Sales Price ($/Unit) 2015-2020
Chart Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Price ($/Unit) 2015-2020
Chart Middle East Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Middle East Anti-Obesity Drugs (Anti-obesity Medication) Sales Price ($/Unit) 2015-2020
Chart Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Price ($/Unit) 2015-2020
Chart GCC Anti-Obesity Drugs (Anti-obesity Medication) Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart GCC Anti-Obesity Drugs (Anti-obesity Medication) Sales Price ($/Unit) 2015-2020
Chart Global Anti-Obesity Drugs (Anti-obesity Medication) Market Segmentation (Region Level) Sales Volume 2015-2020
Chart Global Anti-Obesity Drugs (Anti-obesity Medication) Market Segmentation (Region Level) Market size 2015-2020
Chart Anti-Obesity Drugs (Anti-obesity Medication) Market Segmentation (Product Type Level) Volume (Units) 2015-2020
Chart Anti-Obesity Drugs (Anti-obesity Medication) Market Segmentation (Product Type Level) Market Size (Million $) 2015-2020
Chart Different Anti-Obesity Drugs (Anti-obesity Medication) Product Type Price ($/Unit) 2015-2020
Chart Anti-Obesity Drugs (Anti-obesity Medication) Market Segmentation (Industry Level) Market Size (Volume) 2015-2020
Chart Anti-Obesity Drugs (Anti-obesity Medication) Market Segmentation (Industry Level) Market Size (Share) 2015-2020
Chart Anti-Obesity Drugs (Anti-obesity Medication) Market Segmentation (Industry Level) Market Size (Value) 2015-2020
Chart Global Anti-Obesity Drugs (Anti-obesity Medication) Market Segmentation (Channel Level) Sales Volume (Units) 2015-2020
Chart Global Anti-Obesity Drugs (Anti-obesity Medication) Market Segmentation (Channel Level) Share 2015-2020
Chart Anti-Obesity Drugs (Anti-obesity Medication) Segmentation Market Forecast (Region Level) 2020-2025
Chart Anti-Obesity Drugs (Anti-obesity Medication) Segmentation Market Forecast (Product Type Level) 2020-2025
Chart Anti-Obesity Drugs (Anti-obesity Medication) Segmentation Market Forecast (Industry Level) 2020-2025
Chart Anti-Obesity Drugs (Anti-obesity Medication) Segmentation Market Forecast (Channel Level) 2020-2025
Chart by Drug Varieties Product Figure
Chart by Drug Varieties Product Advantage and Disadvantage Comparison
Chart Prescription Drugs Product Figure
Chart Prescription Drugs Product Advantage and Disadvantage Comparison
Chart OTC Drugs Product Figure
Chart OTC Drugs Product Advantage and Disadvantage Comparison
Chart by Acting Product Figure
Chart by Acting Product Advantage and Disadvantage Comparison
Chart Peripherally Acting Anti-obesity Drugs/Centrally Acting Anti-obesity Drugs Product Figure
Chart Peripherally Acting Anti-obesity Drugs/Centrally Acting Anti-obesity Drugs Product Advantage and Disadvantage Comparison
Chart Childhood (0-6) Clients
Chart Juvenile (7-17) Clients
Chart Youth (18-40) Clients
Chart Middle Aged (41-60) Clients
Chart Elderly (Above 60) Clients
Research Methodology:
Anti Obesity Drugs (Anti obesity Medication) Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|